Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT05986552

The Influence of Treatment Format on Schema Therapy for Borderline Personality Disorder

The Influence of Treatment Format on Effectiveness of and Dropout From Schema Therapy for Borderline Personality Disorder: Individual vs. Combined Individual Group Schema Therapy

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
132 (estimated)
Sponsor
University of Amsterdam · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to compare etc. in patients with borderline personality disorder pure individual schema therapy to combined individual-group schema therapy. The main questions it aims to answer are: * is there a difference in effectiveness? * is there a difference in (early) treatment dropout? Participants will receive either * individual schema therapy or * combined individual-group schema therapy. Researchers will compare individual to combined individual-group schema therapy see if there is a difference in effects and/or a difference in dropout from treatment.

Detailed description

Schema Therapy (ST) for Borderline Personality Disorder (BPD) was originally developed and tested as an individual treatment. Since 2009 group-ST became popular as an supposedly efficient alternative. A RCT found combined individual-group ST to be superior to predominantly group-ST. Thus, individual ST is important. The question arises how combined individual-group ST compares to purely individual ST. This study compares the two formats of ST in a multicenter randomized clinical trial (RCT). The primary outcomes are severity of BPD and (early) treatment dropout. Secondary outcomes include: measures of specific BPD-symptoms; schemas and schema-modes; general mental symptoms; general functioning; and happiness. Moderators hypothesized to predict what patient characteristics are related to differences in effectiveness between the 2 formats are also tested. At least 132 BPD patients from at least 2 sites will be randomized to combined individual-group ST or individual ST. Treatments will take 2 years. Assessments take place every 6 months, and 1 year after end of treatment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALIndividual Schema Therapy (IST)IST is a form of empirically supported specialized psychotherapy for personality disorders. It is delivered in individual sessions by trained therapists.
BEHAVIORALIndividual-Group Schema Therapy (IGST)IGST is a form of empirically supported specialized psychotherapy for personality disorders. It is delivered in the combination of individual sessions and group therapy sessions by trained therapists.

Timeline

Start date
2023-11-10
Primary completion
2027-03-01
Completion
2027-12-30
First posted
2023-08-14
Last updated
2025-01-20

Locations

2 sites across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05986552. Inclusion in this directory is not an endorsement.